DISCOVERY AND INCIDENCE Micrococci were first described by Koch in 1878 (97) , and the identification of Staphylococcus aureus as a human pathogen followed shortly thereafter through the work of Ogston (117) . In the following decades, it became apparent that S. aureus ranks among the most common causes of bacterial infections in humans, producing a broad spectrum of diseases ranging from superficial skin suppurations to life-threatening septicemias. Along with Escherichia coli, it also heads the list of agents that are responsible for hospitalacquired infections.
Soon after their discovery, S. aureus isolates were observed to elaborate soluble substances that evoked inflammatory reactions after inoculation into experimental animals (51, 161a) . The production of one or several hemolytic agents could be detected through cultivation on blood agar, and development of a clear zone of beta-hemolysis was often taken as a criterion for diagnosis of this bacterium. The subsequent introduction of a positive coagulase test as the sole criterion for identifying S. aureus did not generate any conflict, since beta-hemolytic strains were, virtually without exception, coagulase producers.
The first serious research into alpha-toxin was sparked by 734 BHAKDI AND TRANUM-JENSEN are poorly understood (11, 59, 130, 168) . The present review will be confined to a discussion of alpha-toxin.
EARLY FUNCTIONAL STUDIES Interested readers are referred to earlier reviews (11, 59, 83, 108, 130, 168) for summaries of data on the many functional studies that were performed in the period from 1940 to the mid-1960s. The review by Wiseman (168) should be consulted for information on the lethal and dermonecrotic doses determined in various animal models. Although those early studies were performed with material that could not meet current-day demands for purity, a number of fundamental observations were made. One remarkable finding related to the variation in susceptibility to lysis exhibited by erythrocytes of different animal species (see references 50, 83 , and 108 for summaries of these data). For example, an approximately 400-fold-higher concentration of alpha-toxin was required to lyse human erythrocytes compared with rabbit erythrocytes. In addition to erythrocytes, a wide variety of cells including macrophages, skin epithelium, rabbit kidney cells, fibroblasts, smooth muscle cells, and mast cells responded to toxin attack (see reference 83 for compilations). Diverse reactions in these cells were noted; they included liberation of lysosomal enzymes and spastic contraction of smooth muscle cells (83, 171) . These data were significant because they gave an early indication that the action of alpha-toxin was not confined to erythrocytes and that nucleated cells might respond to toxin attack with a spectrum of secondary reactions. Although it is possible that some of the observed phenomena were evoked by contaminants in the toxin preparations, this basic message has proved to be correct.
At that time, neither the mechanism of toxin action nor the cause of its cellular effects was understood in any detail. Following the introduction of analyses of lysis kinetics by Bernheimer (for reviews, see references 11 and 108), studies conducted by Cooper et al. (49) led them to propose that hemolysis involved a defined sequence of events: first, the interaction of toxin with cells; second, release of K+ ions; and, finally, hemolysis. How the hemolytic action of alphatoxin could be conceptually linked to its capacity to provoke pathological reactions in nucleated cells remained enigmatic, as did the cause of its lethal effect. At one stage, lethality was proposed to derive from attack on the central nervous system, since electroencephalography indicated collapse of brain bioelectric activity (52, 83) . In support of this contention, one study purported to show that intravenously applied radiolabeled toxin accumulated not only in the kidneys and lungs but also in the brain (85) . This claim has been contested in a recent investigation in which functionally intact radiolabeled toxin was not detected in the central nervous system of mice that received lethal and sublethal toxin doses (28) . The question of whether toxin exerts pathophysiologically relevant effects via its action on the central nervous system should therefore today be regarded critically. Other earlier work provided evidence that alpha-toxin promoted vasospasm of blood vessels (146, 147) , possibly as a result of its action on smooth muscle cells (42, 171) . According to a preliminary report (mentioned in reference 83), cardiac output also declined after toxin application, supporting the notion that lethality may be due primarily to cardiovascular collapse. As will be discussed in this review, evidence has now accumulated that alpha-toxin preferentially attacks endothelial cells and thrombocytes and that secondary reactions triggered in these cells can lead to deleterious disturbances in the microcirculation and to the development of pulmonary edema. These recent results therefore support the concept that the acute lethal action of alpha-toxin is probably due to its effects on cells that are involved in the maintenance of hemostasis.
Despite the numerous studies describing biological effects of alpha-toxin in vivo and in vitro, its relevance in humans has remained the subject of continuous debate. The intrinsic resistance of human erythrocytes against toxin action fostered the impression that a pathogenic role for this agent might be confined to certain animal species only. Staphylococci secrete a number of other toxic substances including leukocidin, coagulase, proteases, and lipase, which many consider to contribute more significantly than alpha-toxin to bacterial virulence in humans. In this context, however, one early study deserves special mention. Siegel and Cohen (136) reported that application of alpha-toxin to platelet-rich human plasma induced platelets to undergo shape change and aggregation, processes that were accompanied by a net procoagulatory effect. The platelets leaked NAD+ and K+, but not protein; hence, frank cell lysis apparently did not occur. The authors concluded that the ability of alpha-toxin to directly influence a major component of hemostasis might be clinically relevant. They anticipated that they had "identified a human cell (or cell fragment) highly susceptible to this agent" (136) . At approximately the same time, Bernheimer and Schwartz also noted that rabbit platelets were highly sensitive to the action of alpha-toxin (14) . A confirmatory report subsequently provided electron micrographs that demonstrated swelling, but no lysis, of toxin-treated human platelets (105) .
More than 20 years elapsed before this important theme was further investigated. The observation that human platelets are highly sensitive targets for alpha-toxin was confirmed (23) . The need to rectify the prevailing dogma that alpha-toxin does not damage human cells was underlined by the subsequent identification of monocytes (22) and endothelial cells (140) as two other highly susceptible human cell types. The procoagulatory effect of alpha-toxin was shown to derive from assembly of prothrombinase complexes on the platelet surface, a major contributing factor being the exocytotic release of factor V from platelet granules (7).
These findings are mentioned here because they introduce us to two basic questions. Why does alpha-toxin damage human platelets but not erythrocytes or granulocytes? Why do damaged platelets secrete factor V? The resolution of these problems has led to a general appreciation of how membrane-damaging toxins can ultimately evoke pathophysiological reactions that may be relevant to the pathogenesis of disease.
IDENTIFICATION OF ALPHA-TOXIN AS A PORE FORMER
The modern era of alpha-toxin research was heralded by publications in the mid-1960s describing methods for isolating highly purified toxin (13, 98, 102) . Molecular weights given in the early investigations ranged from 26,000 to 36,000 (for reviews of the earlier literature, see reference 108). Several groups had certainly obtained very pure alpha-toxin (13, 102, 137, 138) , and one molecular weight analysis by ultracentrifugation was performed by Arbuthnott et al. in 1967 (5) . A later detailed study (17) at sedimentation equilibrium was 33,000 to 34,000, and the sedimentation coefficient was 3.3S (17) . These data were in fair agreement with previous results of Lominski et al. (102) , McNiven et al. (112) , and Six and Harshman (137, 138) , who had reported a sedimentation coefficient of 3S and a molecular weight estimate of 28,000 to 30,000. Pioneering work on the mechanism of toxin action was conducted in 1967 to 1973 by Arbuthnott and coworkers and Bernheimer and coworkers (5, 6, 12, 60, 61, 165) . These investigators reported that membranes of cells treated with high doses of alpha-toxin carried annular structures of approximately 10 nm in diameter that could be detected by electron microscopy. Fortuitously, similar structures were found when purified toxin solutions were heated to 60°C (in the absence of cells). (112) finally led to the proposition that the rings represented 12S hexamers formed through aggregation of native 3S toxin monomers (6, 11, (59) (60) (61) . Similar ring structures could also be generated on liposomal membranes devoid of protein (6, 60) . From these observations, the following conclusions were drawn: (i) alpha-toxin bound firmly to target membranes; (ii) binding did not require the presence of protein receptors; (iii) binding was accompanied by the formation of ring-structured toxin oligomers, probably hexamers; and (iv) binding presumably caused membrane damage, albeit via an unknown mechanism.
Cassidy et al. (42) confirmed that highly purified toxin interacted with protein-free liposomal membranes and extended these observations by demonstrating that the liposomes became damaged and leaked trapped marker molecules. Their studies corroborated earlier work by Colacicco and Buckelew (46) , who had demonstrated a disruption of lipid monolayers by alpha-toxin. In 1973 to 1975, Thelestam et al. (150, 151, 153) showed that nucleated cells attacked by alpha-toxin leaked low-molecular-weight markers while retaining RNA. They consequently alluded to functional "holes" that were apparently produced by alpha-toxin in the plasma membrane. These studies were in accord with the early observation of Siegel and Cohen (136), since they indicated that the membrane lesions produced by alphatoxin were of finite size.
Today, it is obvious that the above observations uniformly pointed to a pore-forming action of alpha-toxin. In the mid-1970s an analogous situation had arisen in the complement field. Cells damaged by complement appeared to carry functional membrane lesions of finite size, and annular structures could be observed attached to these membranes.
In 1972 Mayer (106) proposed that complement proteins C5 to C9 formed the annular structures through their assembly into macromolecular CSb-9 complexes that inserted into the bilayer to create aqueous transmembrane pores. The originality of this hypothesis, which was initially greeted with skepticism, lay in the assumption that primarily watersoluble plasma proteins might transform themselves into amphiphilic moieties, presumably through conformational changes leading to an exposure of lipid-binding domains. Mayer's hypothesis was subsequently confirmed by ultrastructural, biochemical, and functional studies, the CSb-9 complex thus becoming the first macromolecular pore-forming cytolysin to be identified (15, 156) .
The conceptual basis for the complement work was derived in part from discoveries made in the early 1970s that small amphiphilic molecules of microbial origin such as the polyene antibiotics as well as peptides such as gramicidin A could spontaneously insert into cell membranes and form discrete pores (74, 96 128). Its discovery explained several earlier observations, e.g., that production of many exoproteins in S. aureus is strictly synchronized and appears mainly during the postexponential or stationary phase (1, 48) and that it was possible to isolate mutants in which expression of several exoproteins was simultaneously affected (27, 47, 172) . The regulatory chromosomal locus has been cloned (115) .
The toxin does not harbor extensive stretches of hydrophobic amino acids. Analysis of the circular dichroism of the dissolved toxin indicates an abundance of ,B-sheet structure (68%) and very little a-helix (10%) (155) . According to Tobkes et al. (155) and Ikigae and Nakae (79) (80) (81) , the overall secondary structure of oligomeric toxin does not significantly differ from that of the monomer. This could indicate that oligomerization does not involve extensive alterations in the secondary structure of the molecule. In a theoretical analysis, Menestrina has concluded that at least 10 amphiphilic n-sheet structures, each of 3 nm putative length, can be constructed (113) . The central portion of the toxin sequence contains an abundance of glycine residues. The high probability of random coil here could indicate that this region serves as a hinge for folding between the C and N domains. In addition, there is at least one stretch of amino acids that could produce an amphiphilic a-helix. We have pointed out that pore-forming proteins theoretically need not contain stretches of hydrophobic amino acids, but are able to produce pores by the association of amphiphilic ,B-sheets or a-helices (25, 26) . One surface will thereby interact with lipid, whereas the other will repel apolar membrane constituents, thus creating an aqueous passage. To date, the structural evidence obtained on all pore formers is consistent with this concept. It is noteworthy that the most detailed structural knowledge of a pore-forming protein is from a bacterial porin (82) . A recent projection map shows three rings of electron density in approximate threefold symmetry.
Each ring is interpreted as arising from 13-sheet structures oriented perpendicular to the membrane plane. The bacterial porins show a high degree of sequence homology, and have large amounts of amphipathic ,B-sheets.
Several pore formers including complement component C9 (154) and E. coli hemolysin (34, 103) show Ca2e-binding activity. With these proteins, pore-forming capacity is lost following prolonged incubation in EDTA. Alpha-toxin does not share this property, and no requirement for divalent cations for binding and expression of lytic function has been recognized.
Two methods currently in use are simple enough to be recommended for preparative isolation of alpha-toxin. The first involves a one-step purification of a fast protein liquid chromatography column (101) . The second involves singlestep ion-exchange chromatography of concentrated bacterial culture supernatants over CM-Sephadex (22) . The purity of the toxin preparations obtained by the latter method exceeds 95%, as judged by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and analytical centrifugation. Toxin preparations can be transferred to 50 mM ammonium acetate and lyophilized. In this form, the protein is stable for years at -20°C and for weeks at room temperature. (Earlier findings of marked instability of;the toxin, discussed in reference 168, were obviously due to the presence of contaminating proteases.) The Am80 of a 0.5-mg/ml solution is approximately 1.0. The toxin is soluble in water or any aqueous buffer at pH 5 to, 9. X-ray crytallographic analyses of native or hexamerized toxin are not yet possible. Although large-scale purification of native toxin is not a problem, attempts to obtain crystals have uniformly failed owing to the propensity of the protein to form amorphous or filamentous aggregates. Isolation of homogeneous hexamer preparations is demanding, and the possibility of contamination with oligomers containing fewer protomers (e.g., tetramers and pentamers) cannot be excluded. The amphiphilic nature of the hexamers renders their handling even more difficult.
MODES OF PRIMARY BINDING TO TARGET MEMBRANES As alpha-toxin became available in a highly purified form, investigations were launched to analyze the mechanisms responsible for the different susceptibilities of different cell types and species. The following findings together constituted a puzzle that challenged the wit of investigators (discussed in detail in reference 108). First, erythrocytes from different species exhibit widely different susceptibilities to the toxin (108) . Second, protein-free liposomes can be damaged by alpha-toxin (42, 60, 165) , and liposomes prepared with lipids extracted from rabbit or human erythrocytes exhibit similar sensitivity (42) . Third, the relative amounts of toxin becoming bound to either susceptible or resistant cells appear to be small. As early as in 1965, Bernheimer and Schwartz (14) reported that toxin-mediated alterations of platelet function were not accompanied by detectable consumption of the toxin. Arbuthnott later estimated that only approximately 5% of '4C-labeled toxin bound to intact rabbit erythrocytes (108) . These observations initially appeared to place some constraints on the concept that alpha-toxin exerted its cytolytic action via firm binding to the membranes. (On the other hand, alternative proposals that alpha-toxin might be an enzyme [169, 170] did not withstand the test of time.)
Against this background, searches were conducted to detect "receptors" on the highly toxin-sensitive rabbit erythrocytes. Definitive binding studies can, however, be performed only if a suitable tracer that permits labeling to high specific activity without significant loss of biological function is available. In fact, this demand was not met in any published study. The preparation of a suitably labeled toxin tracer has been difficult, and several studies purportedly demonstrating the existence of toxin receptors were thus based on indirect approaches.
Kato and Naiki (90) found that gangliosides bound and inactivated alpha-toxin and therefore proposed a role for these molecules as surface receptors. However, binding may have been due simply to electrostatic interactions. In fact, Buckelew and Colacicco (36, 46) observed that the rate of penetration of alpha-toxin was lowest in lipid monolayers containing gangliosides, whereas the highest rates were measured in monolayers containing cholesterol without gangliosides. By extrapolation, gangliosides may actually prevent rather than augment the membrane-damaging action of alpha-toxin.
Maharaj and Fackrell have postulated that the erythrocyte anion antiporter (band 3, capnophorin) is the toxin receptor (104). Their conclusion was based on indirect evidence including: (i) reduction in sensitivity toward toxin action exhibited by rabbit erythrocytes following pronase or chymotrypsin digestion (these enzymes cleave band 3); (ii) reduction in sensitivity of the cells through binding of certain lectins (putative shielding of receptors), as well as after neuraminidase treatment; and (iii) inactivation of alpha-toxin by purified band 3. The collective data could indicate a role for sugar residues present on one or several surface glycoproteins in binding of alpha-toxin. A protective effect of lectins on hemolysis of rabbit erythrocytes was also reported by Kato et al. (92) . The identity of band 3 as the receptor must, however, be shown by more rigorous criteria. The number of specific binding sites on rabbit erythrocytes is orders of magnitude smaller than the number of band 3 molecules (see below), and the possibility that preparations of the latter were contaminated with a minor component cannot be dismissed. The contention that band 3 represents the toxin receptor has been neither explicitly refuted nor confirmed by others. We have found that washing cells several times does not suffice to remove proteases added to cleave band 3 protein. Residual proteases can then cleave toxin when it is added to the incubation mix and can thereby generate artifacts (15) . We have also not been able to decrease the sensitivity of rabbit erythrocytes toward alphatoxin by neuraminidase treatment (15) . Harshman and Bondurant (69) found no differences in susceptibility to alphatoxin of murine erythroblasts compared with mature cells and adult erythrocytes. Their results therefore did not support the view that any of the molecules which are synthesized late during differentiation of erythrocytes (including band 3) represent the receptor for alpha-toxin on murine cells. Mouse erythrocytes display intermediate sensitivity toward alpha-toxin (108) , probably owing to the presence of binding sites of lower affinity (75) .
The only detailed binding study involving radiolabeled toxin was published in 1976 by Cassidy and Harshman (40) . Their tracer was radioiodinated to high specific activity but unfortunately retained only 10% of the original hemolytic titer. The data indicated that rabbit, but not human, erythrocytes express a limited number of surface receptors for alpha-toxin. Binding was optimal at 24°C and appeared irreversible. The authors concluded that presence of these receptors was responsible for the high sensitivity of rabbit erythrocytes. They concluded that at high concentrations, the toxin could bind via another, unspecific interaction to resistant cells such as human erythrocytes. Since ring structures could be detected only on cells lysed at high toxin concentrations, the possibility was considered that membrane damage invoked at high and at low concentrations might occur via different mechanisms. This in turn would place the significance of hexamer formation in question.
Subsequently, Phimister and Freer (126) performed binding experiments involving iodinated and functionally intact toxin. They reported a uniform binding of approximately 20% over the range of concentrations tested. These results thus did not support the receptor concept. Binding studies conducted in our laboratory but using the enzyme-linked immunosorbent assay (ELISA) also generated no evidence for the existence of receptor on rabbit erythrocytes (128) . However, the sensitivity of the latter method would not have permitted a small number of specific binding sites to be detected.
A very recent study has resolved the receptor controversy by showing that the major results and conclusions of Cassidy and Harshman (40) were in fact correct. Hildebrand et al. labeled alpha-toxin to high specific activity with retention of functional activity. Their binding studies demonstrated that rabbit erythrocytes express an average of 1,500 to 2,000 high-affinity, specific binding sites for alpha-toxin (76 
MODE OF PORE FORMATION
We have proposed that alpha-toxin binds in monomer form to membranes and that hexamerization occurs upon their subsequent collision during lateral diffusion in the bilayer (129) . In support of this contention, application of alpha-toxin at low doses to rabbit erythrocytes at 0°C resulted in binding without substantial hexamer formation and without lysis. After washing and incubation of the cells at 37°C, hexamerization accompanied by lysis occurred (129) . Because unbound toxin had been washed away before cells were warmed, hexamer formation must have been due to oligomerization of the membrane-bound monomers. Blomquist and Thelestam (31) also treated adrenocortical Y1 tumor cells with toxin at 0°C and noted that the membranebound toxin molecules exhibited different properties from the lytic hexamers forming at 37°C. Thus, for a short time after binding at low temperature, cell-bound (probably monomeric) toxin could be inactivated by incubation with polyclonal antibodies or by trypsin treatment. These properties were lost after incubation of the cells at 37°C.
The molecular events underlying pore formation have not been elucidated, and a purely hypothetical model is presented in Fig. 2 . Each toxin molecule is proposed to contain two domains (at and ,B) that display affinity for each other.
Binding to a lipid bilayer serves to orient the molecules such that these domains are in the optimal position to interlock when two molecules collide during lateral movement in the membrane plane. Dimer formation could be accompanied by insertion of amphiphilic P-sheet domains into the bilayer. In solution, toxin molecules are nonoriented, so the probability that two molecules will collide in the orientation required to trigger unfolding is minimal. In fact, hexamers do form spontaneously, but slowly, in aqueous solution. The primary function of binding sites on membrane surfaces will be to orient the toxin molecules uniformly so that they are primed for unfolding when collision occurs. The oligomerization process ends when ring-structured hexamers have formed in which all reaction sites (a and I) are mutually occupied.
What is the fate of integral membrane components that are displaced from their original locations? Theoretically, two possibilities exist. First, lipids and integral membrane proteins might be expelled from the membrane and released as micelles or small aggregates into the aqueous phase. Alternatively, these components may be forced laterally apart. We have treated isolated erythrocyte membranes with low and high doses of alpha-toxin and searched for lipids in the membrane supernatants. In no case could any expulsion of lipid ever be detected (15) . Therefore, we believe that integral components are forced aside and that liberation of integral membrane constituents into the environment should generally not occur. It may be noted, however, that hexamers generated at high toxin concentrations tend to aggregate and small membranes blebs can form upon prolonged standing that are released as microvesicles crowded with hexamers. This is a late phenomenon and is not related to the primary mode of membrane damage.
STRUCTURE AND COMPOSITION OF PORES
First, we consider whether pores are uniformly composed of hexamers and whether membrane constituents may contribute towards their structure. When toxin-treated membranes are solubilized with mild detergents, the toxin elutes upon molecular sieve chromatography as a symmetrical peak corresponding to the hexamer form (62) . Isolated hexamers can be reincorporated into lecithin liposomes. They present the typical cylindrical appearance in the electron microscope and generate a single protein band corresponding to the alpha-toxin monomer in SDS-PAGE (62) . These data indicated that hexamers represent the predominant form of toxin pores and that membrane constituents do not participate in forming the channel. The major assumption upon which these conclusions rest are (i) that lower-molecular-weight oligomers, if they exist, should also remain intact in mild detergents, and (ii) that detergent will not dissociate any bound membrane proteins. Although validation of these assumptions has not been possible, the fact that toxin alone could damage protein-free liposomes indicated that the straightforward hexamer concept could be correct.
Another method of analyzing the physical states of alphatoxin is to solubilize membranes with SDS at ambient temperature and run gels in the cold. Toxin hexamers are not dissociated appreciably unless heated in SDS (41, 62) , and the electrophoresed toxin can be detected by autoradiography or by Western immunoblotting. All studies involving this approach have detected monomers and hexamers only (Fig. 3) . Hence, if intermediate forms exist, they are not stable in SDS. Evidence for additional association of membrane proteins has never been obtained, but again, these interactions might be disrupted by the detergent.
One unresolved puzzle relates to the fate of the specific binding sites during hexamerization. There is no evidence that the number of toxin hexamers increases with time at low toxin doses; i.e., the number of hexamers formed is fixed relative to the number of binding sites (76) . This excludes a catalytic action of the acceptor, and, by inference, the acceptor is likely to remain associated with the hexamerized toxin. Because the number of binding sites per cell is small, isolation of pores generated at low toxin concentrations (e.g., 100 to 500 ng/ml) poses a technical challenge. Such an undertaking may nevertheless prove worthwhile, since these pores could differ in structure and functional properties from those generated following nonspecific absorption to the membrane at high toxin concentrations.
Second, we consider the question regarding the structure and orientation of hexamers in the membrane. Related to this is the question of whether generation of a hexamer will inevitably result in the production of a pore.
Thelestam et al. (149) and Harshman et al. (70) have reported that membrane-bound alpha-toxin can be labeled with an apolar photolabel, thus corroborating the contention that polypeptide domains become inserted into the membrane. Photolabeling may become a useful tool for identifying the membrane-inserted domains of the alpha-toxin molecule in the future. In the electron microscope, toxin hexamers are seen as relatively thick-walled cylinders approximately 4 nm high and 10 nm wide, apparently harboring a central pore of 1 to 2 nm in diameter (62) . The cylinders are perpendicular to the membrane plane. Functional studies have indeed shown that toxin-treated membranes harbor pores of 1 to 2 nm in effective diameter. Could such defects in the lipid bilayer be due to egress of molecules via leaky patches around the cylinder, i.e., between inserted protein and lipid, as proposed by Bashford et al. (9) ? It should be realized that the interaction between toxin and lipid must be very tight, since it can be disrupted only by detergents (25, 26, 62) . We see no reason to assume that large, hydrophilic molecules should be able to overcome such a barrier, and we will therefore return to the concept of a pore passing through the center of the hexamer. A transmembrane leak would be generated if each hexamer inserted sufficiently into the bilayer and if the channel extended through the entire length of the hexamer in an open configuration. Regarding the depth of insertion, electron microscopy indicates that the bulk of the toxin hexamer is located outside the lipid bilayer.
Toxin cylinders appear to project 3 to 4 nm from the membrane surface into the extracellular (aqueous) phase (62) . Since the thickness of the hexamer wall is 3 to 3.5 nm, an approximate molecular weight of 150,000 to 200,000 can be calculated for the extramembranous domain. Although this molecular weight estimate is crude, it does indicate that only a minor part of the hexamer is left to form the intramembranous pore domain. The walls of this domain may be quite thin, and the possibility that the hexamer does not penetrate through the entire bilayer must also be considered. Should this be true, diverse membrane factors might obviously influence or even inhibit the formation of pores.
Recently, Olofsson et al. (118, 119) reported low-resolution structural analysis of toxin pores by using image processing of electron micrographs. They examined single oligomers randomly distributed in platelet membranes (119) , as well as oligomers that had accumulated into two-dimensional crystals in artificial lipid bilayers (118) . Unexpectedly, the two oligomer preparations exhibited quite different structures. The single particles had smaller internal diameters of 7 nm as opposed to 10 nm in the crystals. Remarkably, whereas a hexamer structure evolved from analysis of single particles, the crystals showed either four or eight protein peaks. Moreover, a lid that partially occluded the central channel appeared to be present in the crystalline oligomers. Occlusion of the central pore was not observed in the toxin hexamers formed on platelets. Further work is obviously needed to clarify these apparent discrepancies. At A second finding that cautions against the generalization that hexamer formation is always accompanied by membrane permeabilization is that alpha-toxin binds to certain cells with formation of hexamers, but without invoking membrane leakiness. This has been observed with human granulocytes treated with relatively high toxin doses (20 ,ug/ml) at 22 to 37°C (75 (114) .
Several recent investigations in which liposomes were used as targets indicate that cholesterol (58), unsaturated fatty acids (80, 81) , and phosphatidylcholine (164) augment the efficiency of toxin attack. Since incubation with phosphatidylcholine led to toxin inactivation, it has been proposed that choline-containing phospholipids may be involved in binding of the toxin (164) . Toxin hexamerization was also found to be induced by deoxycholate (17) , whereby marked and unexplained differences in the extent of oligomer formation have been noted to be dependent on the toxin and deoxycholate charge (15). Raff et al. (127) observed inactivation of alpha-toxin by hydrocortisone and methylprednisolone, which might also have been due to hexamer formation induced by the sterols.
In a recent study, alpha-toxin was applied to asymmetrical planar lipid bilayers lined on one side with bacterial lipopolysaccharide and on the other with phospholipids (135) . Application to the phospholipid face but not to the lipopolysaccharide face resulted in pore formation. Thus, several explanations have now emerged for the early finding that alpha-toxin does not damage bacterial cell membranes (12): lack of cholesterol, paucity of exposed phosphatidylcholine, and shielding by lipopolysaccharide molecules.
Determination of hemolytic titer represents an important means of checking the quality of a toxin preparation. The standard procedure is to add a suspension of rabbit erythrocytes to serially diluted toxin. The reciprocal of the dilution eliciting 60% lysis within 1 h at room temperature gives the number of hemolytic units (HU), which can be expressed per milligram of protein. The specific activity of purified alphatoxin is in the range of 40,000 HU/mg of protein, when assessed by addition of 1 volume of a 2.5% erythrocyte suspension (2.5 x 10' cells per ml). The hemolytic titer is higher when incubation times are prolonged and reaches 50,000 to 100,000 HU/mg after 4 h at room temperature. It is noteworthy that toxin binding and hemolysis are most effective at room temperature. Many of the early studies were conducted with toxin preparations that exhibited markedly lower activity, and the possibility that either a substantial part of the toxin was inactive (e.g., in aggregated form) or the preparations were contaminated must be considered.
STRUCTURE-FUNCTION RELATIONSHIPS
The subject of structure-function relationships is currently a problematic area in alpha-toxin research. Several studies purport to have identified molecular domains required for membrane binding, as well as domains that are involved in oligomerization and pore formation. Other studies have attempted to identify amino acid residues that are essential for toxic function by using biochemical modification methods.
Harshman et al. generated monoclonal antibodies against N-and C-terminal peptide domains (68, 73) . Because an antibody directed against an epitope located in the C-terminal fragment inhibited the binding of alpha-toxin to cells, the binding region was proposed to reside in the C-terminal half of the molecule. An antibody against the N-terminal half did not inhibit binding, but inhibited oligomerization of the toxin. On the basis of radioiodination experiments (39), Cassidy and Harshman suggested that a tyrosine residue within the N-terminal domain is essential for the oligomerization process. Unfortunately, antibody molecules, with a molecular mass greatly exceeding that of alpha-toxin, may not be sufficiently accurate probes to clarify structurefunction relationships, and antibody binding could pose a steric hindrance to an interaction involving a molecular region distinct from the epitope. Ultimately, a binding domain must therefore be identified by using more rigorous criteria, e.g., competition of binding of the native molecule.
However, successful competition studies have not been reported. Alternatively, binding of the respective polypeptide domain or toxin fragment might be demonstrated directly. Binding data are available in one case from experiments by Blomquist and Thelestam (32, 33) . These authors isolated a naturally occurring fragment of alpha-toxin, iden- tified as the C-terminal half, that bound to cells (33) and apparently possessed full hemolytic activity (32) . These data thus indicated that only approximately half of the alphatoxin molecule is required for pore-forming activity in erythrocytes, and the N-terminal half would not be necessary for oligomerization. Although limited proteolysis with trypsin also generates fragments of similar size by cleaving bonds in the center of the molecule, the ensuing C-terminal fragment of molecular weight 17,000 (the 17K fragment) is entirely devoid of binding or lytic properties. A remarkable and unvoiced conclusion emerging from these considerations is that a small stretch of amino acid residues present in the 18K fragment of Blomquist and Thelestam (32, 33) but absent in the C-terminal 17K trypsin fragment must be involved in both the binding and oligomerization processes.
In summary, there is currently some reason to assume that the binding domain of alpha-toxin is located in the C-terminal half of the molecule. It is not known whether the domain is represented by a linear sequence or whether several parts of the molecule participate in forming a conformational epitope.
Blomquist and Sj0rgen (30) have reported that different monoclonal antibodies vary in their respective abilities to inhibit the hemolytic, dermonecrotic, and lethal effects of alpha-toxin. For example, one antibody did not neutralize the hemolytic or dermonecrotic effects, but did abrogate lethality. Hence, the authors believe that different biological activities of alpha-toxin are carried or evoked by different molecular regions. This contention is provocative because it implies either that the toxin has different binding sites for different cell targets or that the various toxic effects are not uniformly due to hexamer transmembrane pore formation. In a similar context, Blomquist et al. reported that the C-terminal, naturally occurring 18K fragment of alpha-toxin, although hemolytic, was not cytotoxic to Y1 cells or lethal in mice (29, 32, 33) . This fragment appeared to bind to and block the receptor on Y1 cells without incurring any damage, and pretreatment of the cells with the fragment rendered them refractory to subsequent action of native toxin (33) .
Further, the fragment appeared to oligomerize on Y1 cells to form noncytotoxic dodecamers (33) . These very interesting observations have not been corroborated. It is somewhat disappointing that, in the face of the importance of their finding, the authors did not conduct a binding competition study with their toxin fragment. It should be mentioned that Watanabe and Kato earlier claimed that a 17K, C-terminal toxin fragment, although devoid of hemolytic activity, was lethal in mice (163) . However, the N-terminal sequence obtained for their fragment (93) could not subsequently be fitted into any part of the complete amino acid sequence that became available thereafter. This example underlines the need for rigorous criteria to be applied in any study that is aimed at elucidating structure-function relationships at a molecular level.
Fackrell and Hebert (54) reported that treatment of alphatoxin with an arginine-modifying reagent destroyed its hemolytic activity. The concentration of the modifying reagent used was very high, and it was unclear whether the modified toxin failed to bind or whether the oligomerization step was inhibited. More informative studies involving chemical modifications were recently performed by Menestrina and coworkers (43, 124) . First, they found that modification of two or more histidine residues with diethylpyrocarbonate led to both defective binding and defective oligomerization. Their titrations indicated that three histidine residues are available for reaction with diethylpyrocarbonate in the toxin monomer, whereas only one residue is reactive in the membrane-embedded hexamer. Detergent-extracted hexamers appeared to present two reactive histidine residues. The original sequence data of Gray and Kehoe (66) reported three histidine residues at positions 35, 144, and 259; another residue is present at position 48 (94a) . At present, it remains unknown which of the histidine residues are involved in the binding and oligomerization processes, respectively.
In another study, Cescatti et al. (43) found evidence indicating that lysine residues line the channel and influence the electrical properties of the pore. Studies involving sitedirected mutagenesis should be useful for more precise identification of the relevant amino acid residues that take part in the binding and oligomerization processes in the future. (20, 22, 23) .
Death of a particular cell type can, of course, have some primary biological consequences as a direct result of loss of the respective cell function. For example, monocytes and macrophages are effectively killed by alpha-toxin, and this conceivably cripples the phagocytic defence system in tissues (22, 111) . Perfusion of rabbit lungs with very low doses of alpha-toxin causes death and detachment of endothelial cells from the basal membrane, i.e., breakdown of the endothelial permeability barrier with consequent leakage of macromolecules and water from the vascular space into the alveoles (134) . In a related context, Vann and Proctor (160) have found that uptake of S. aureus leads to the death of endothelial cells, possibly owing to intracellular release of alpha-toxin.
Secondary Effects
Until quite recently, a gap yawned between basic studies dealing with the primary mechanism of alpha-toxin action and studies describing cellular reactions and pathophysiological effects. Were such complex phenomena as platelet activation, or lethal effects in general, causally linked to membrane pore formation and, if so, via which mechanisms?
Today, there is increased awareness that the generation of transmembrane pores will trigger pathophysiologically important, secondary cellular reactions (25, 26) . Two facts provide the basis for this. First, the pores are too small to permit egress of cytoplasmic proteins; therefore, molecular (133) (i) Stimulation of eicosanoid production. Calcium ions trigger arachidonic acid metabolism via their participation in the activation of membrane-bound phospholipase. Today, the fact that cells attacked not just by alpha-toxin, but by all pore formers studied, respond with rapid production of prostaglandins or leukotrienes, or both, is therefore not surprising (25, 26) . When these findings were first reported, however, they provided an unsuspected link between the phenomenon of membrane damage and a complex cellbiological reaction (133) . The key role of calcium influx was first documented in experiments utilizing alpha-toxin (133, 141, 143, 144) and was subsequently extended to other cytolysins.
The pattern of eicosanoid production varies qualitatively and quantitatively among different cell species. Each lipid mediator in turn elicits a typical spectrum of cellular reactions, so that long-range consequences may ensue in a complex system (e.g., whole organs). For example, cultured bovine endothelial cells release large amounts of prostacyclin and thromboxane following attack by very low doses of alpha-toxin (143) . Marked production of thromboxane is additionally noted in isolated, perfused rabbit lungs. Thromboxane is known to exert a vasoconstrictive effect on lung vessels. When alpha-toxin is perfused through isolated and ventilated blood-free rabbit lungs, it evokes a steep rise in pulmonary vascular resistance (133) . This is accompanied by a protracted breakdown of the vascular permeability barrier owing to additional, direct cytotoxic effects of the toxin on the endothelial cells (133, 134) . As a result, pulmonary edema develops (Fig. 4) . These experiments have shown that a bacterial cytolysin can thus provoke pulmonary dysfunction and a pathological status resembling adult respiratory distress syndrome.
Alpha-toxin can also trigger production of leukotrienes in polymorphonuclear granulocytes (144) . Owing to the intrinsic resistance of these cells, however, the doses required to evoke this effect are very high. Eicosanoid production in other more susceptible cells (e.g., monocytes and macrophages) has not yet been studied.
(ii) Secretory processes. Calcium ions represent a major trigger for secretion, and alpha-toxin was originally introduced as a tool to study the minimal requirements for exocytosis (3) . Neuroblastoma PC 12 cells permeabilized with the toxin mounted a secretory response upon addition of micromolar amounts of calcium ions to the medium. A requirement for ATP, Mg, or GTP could not be discerned. In Calcium-dependent secretory responses were subsequently documented to occur in platelets, which rapidly secrete large amounts of platelet factor 4 and factor V following attack by alpha-toxin (7, 23) . As originally noted by Siegel and Cohen (136) , the platelets do not lyse, but undergo a swelling reaction and leak ATP. Secreted factor V associates with the platelet surface, forming nuclei for assembly of prothrombinase complexes (Fig. 5) . This constitutes the major pathway responsible for the procoagulatory effects of alpha-toxin (7) . In this connection, earlier observations on "lysosomal labilization" in cells treated with alpha-toxin (83, 84) may have been due to secretion of lysosomal constituents. Exocytosis will probably occur in a large variety of cells permeabilized by alpha-toxin.
(iii) Cellular contractile dysfunction. Calcium ions cause contraction of actin-myosin filaments, and relaxation is an active process requiring ATP. Since toxin-permeabilized membranes leak ATP and cells are flooded with calcium, subsequent dysfunction of the cellular contractile apparatus might be anticipated. Indeed, when Suttorp et al. (142) treated confluent endothelial-cell monolayers with low doses of alpha-toxin, they noted that the endothelial cells contracted, leading to formation of intercellular gaps that permitted free passage of macromolecules across the originally intact monolayer (Fig. 6) . Similar processes, if occurring in vivo, would promote the development of edema.
(iv) Activation of endonucleases. Programmed cell death is widely believed to be caused by activation of endogenous endonucleases, and calcium ions have been implicated as a major trigger for this process. Endonuclease activation has been proposed to represent one of the killing mechanisms of cytotoxic lymphocytes. One study by Hameed et al. (67) reported that DNA degradation also occurred in cells permeabilized by alpha-toxin, and endonuclease activation was proposed to represent a general mechanism which is operative in cells damaged by pore-forming proteins. The observation, although interesting, requires confirmation because the toxin preparation used by the authors was very impure and may have contained endonucleases. Several hypotheses currently accommodate regulatory factors (such as protein kinase C) that could suppress endonuclease activation in the permeabilized cells (109) . At present, the contention that endonuclease activation occurs in toxin-treated cells as an early event appears interesting but requires more extensive study.
(v) Release of cytokines. Human monocytes are highly susceptible to damage by alpha-toxin (22) . Current evidence indicates that alpha-toxin induces rapid processing and secretion of interleukin-li if the interleukin precursor has accumulated intracellularly. Toxin-triggered release of interleukin-l, was very rapid (complete within 60 min) and occurred in the presence of cycloheximide and actinomycin D (Fig. 7) . Alpha-toxin might thus synergize with various stimuli that trigger interleukin-1 synthesis to accelerate and augment release of the cytokine (22) .
(vi) Membrane alterations. Can insertion of an alien protein into the bilayer lead to reorientation of lipid components? According to one study, this may be the case. Schneider et al. (131) detected enhancement of the flip rate of lysophosphatidylcholine from the outer to inner membrane leaflet of erythrocytes in correlation with alpha-toxininduced lysis. By extrapolation, lipid components could possibly flip from the inner to the outer monolayer as well. In this context, indirect evidence exists for a reorientation of membrane constituents in toxin-treated platelets, which were observed to bind factor Va in an augmented fashion. Binding of factor Va to the platelet surface involves negatively charged phospholipids, and augmented binding may have been due to flip-flop of phosphatidylserine from the inner to the outer leaflet. Analogous findings have been made for platelets permeabilized with complement (166, 167) .
(vii) Other effects. Gemmell et al. (63, 64) reported that addition of alpha-toxin to human serum resulted in complement consumption and, consequently, in reduction in opsonic activity of the serum. The relevance of this finding is unclear since the concentration of alpha-toxin used to produce immune complexes was probably very high (of note, their toxin preparation exhibited a specific activity of only 1, 200 HU/mg of protein). In another study, we did not detect significant complement consumption as a result of addition of highly purified, monomeric toxin to serum (16 'rs alpha-toxin directly enhances the phagocytic killing capacity of neutrophils (15) .
Petrini and Moilby (125) reported activation of T lymphocytes ly alpha-toxin. Further investigations in this area, in particular with regard to dose-response relationships, are warranted.
Harshnian and colleagues reported disruption of myelin sheats in isolated rabbit nerves (139) and in mouse brain in vivo and, in vitro (71) by alpha-toxin. Chan and Lazarovici (44) have observed a calcium-independent phosphorylation of several proteins including myelin basic protein after treatment of myelin with alpha-toxin. The same authors found that incubation of PC 12 cells with subcytotoxic doses of alpha-toxin resulted in reduction of epidermal growth factor receptor affinity (99) . Future work should aim at clarifying the underlying mechanisms of these processes and their pathogenic relevance.
According to Kato et al. (89, 94) , alpha-toxin also exerts an inhibitory effect on isolated AMP-dependent protein kinase. The toxin seems to compete with cyclic AMP for a binding site on the regulatory subunit of the enzyme. The biological significance of this finding is unclear since alphatoxin is normally not able to reach a cytoplasmic target.
However, in. conjunction with the observation that flavin mononucleotide inhibits hemolysis of rabbit erythrocytes (91), one might speculate that alpha-toxin interacts specifically with nucleotide-binding sites on several proteins. One of these could possibly be identical with the biologically important acceptor molecule on cell surfaces.
(viii) Repair processes. Thelestam and Moliby reported that cultured cells could recover from toxin attack (152) . This investigation raised some very interesting questions since membrane permeabilization was apparently followed by regaining of bilayer integrity. The mechanism of membrane repair was not studied, and the extent to which other cells can deal with a limited number of toxin lesions is unknown.
Alpha-Toxin as a Biological Tool A number of properties render alpha-toxin an excellent tool for controlled permeabilization of cell membranes. The toxin is very stable, and neither transport nor storage poses any problem. It is soluble in water or any aqueous buffer and is stable over a wide pH range. No ionic requirements have been noted for membrane binding or pore formation, and ,ug/ml) will be perfectly harmless to platelets if the toxin is preincubated for 1 min with normal human serum or with a neutralizing monoclonal antibody (Fig. 8) . In the absence of such a preincubation step, however, the toxin successfully binds to and activates platelets suspended in plasma (23) . An analogous phenomenon has been demonstrated for the attack of E. coli hemolysin on human granulocytes (19 (2, 162) . They demonstrated a deleterious effect of purified alpha-toxin and showed that immunization with highly purified toxoid (but not with beta-toxoid) reduced the lethal edematous form of the disease, although abscess formation was not prevented. Taubler et al. similarly obtained evidence for a role of alpha-toxin in the pathogenesis of subcutaneous lesions in mice (145) . Van (120, 122) , thus also generated evidence for a pathogenic role of alpha-toxin in the mastitis model. In sum, these experiments uniformly indicate that alpha-toxin is truly relevant as a virulent factor in animal infections.
Relevance in Humans
It is presently impossible to prove that alpha-toxin represents a pathogenetic factor in humans. Staphylococcal disease is multifactorial and is usually due to the simultaneous production of several pathogenetic factors including protein A, coagulase, and leukocidin. Attempts to compare the incidence of alpha-toxin production and relate this property to clinical symptoms would hardly be meaningful, and no such studies have been undertaken. Our bias for the pathogenic relevance of alpha-toxin is based on the knowledge that (i) certain human cells including monocytes, endothelial cells, and platelets express high-affinity binding sites and are effectively attacked by the toxin under physiological conditions and (ii) damage occurring to these cells triggers pathological sequelae. Hemostasis disturbances, thrombocytopenia, and pulmonary lesions are often encountered in patients during severe staphylococcal infections.
One way of indirectly demonstrating a significant role of alpha-toxin as a virulence factor may be possible if application of specific hyperimmune globulins were found to be therapeutically effective. Human hyperimmune globulins against alpha-toxin have been prepared, and they are able to suppress all experimental toxic effects in vitro and in vivo (20) (Fig. 9) . Patients with early diagnosis of S. aureus septicemia are candidates for therapy with such hyperimmune globulins, but clinical trials with these antibodies have yet to be conducted.
Theoretically, another approach to relate toxin production MICROBIOL. REV. 
